Latest news with #KeithMeister
Reuters
8 hours ago
- Sport
- Reuters
Braves RHP AJ Smith-Shawver undergoes Tommy John surgery
June 9 - Atlanta Braves right-hander AJ Smith-Shawver underwent season-ending Tommy John surgery on Monday, the Braves announced via social media. Dr. Keith Meister repaired the ulnar collateral ligament in Smith-Shawver's right elbow in Arlington, Texas. Smith-Shawver, 22, will miss part or potentially all of the 2026 season as well, based on the typical timeline. He felt something pop in his elbow during the third inning of his May 29 start at Philadelphia. Smith-Shawver opened the month at the other end of the spectrum when he took a no-hitter into the eighth inning on May 5 versus Cincinnati. He finished with a 1-hitter over eight innings and earned the win in a 4-0 final. Smith-Shawver finished 3-2 with a 3.86 ERA in nine starts this season. He struck out 42 batters in 44 1/3 innings. Still technically a rookie in 2025, he appeared in six games for Atlanta in 2023 and made one start in 2024. --Field Level Media
Yahoo
01-04-2025
- Business
- Yahoo
Argus cuts Illumina target, sees buying opportunity
Argus lowered the firm's price target on Illumina (ILMN) to $100 from $170 and keeps a Buy rating on the shares. The stock has fallen significantly over the past several months amid geopolitical tensions, antitrust issues, and slowing product sales, the analyst tells investors in a research note. However, the firm believes Illumina 'appears to be turning the corner,' delivering multiple quarters of margin growth, launching new products and services, and providing 'strong' earnings guidance for 2025. The stock's 'discounted price' offers a buying opportunity, contends Argus. Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks. Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See Insiders' Hot Stocks on TipRanks >> Read More on ILMN: Disclaimer & DisclosureReport an Issue Illumina price target lowered to $122 from $150 at Guggenheim Corvex's Keith Meister to join Illumina's board, WSJ reports Illumina elects Dr. Scott Gottlieb as Chair, Keith Meister to join board No change to Illumina story amid board changes, 'eventful' 24 hours, says BofA Activist Investors Seize More Control of Illumina Amid Weakness Sign in to access your portfolio
Reuters
25-03-2025
- Business
- Reuters
Activist investor Keith Meister to join Illumina's board, WSJ reports
March 25 (Reuters) - Activist investor Keith Meister will join the board of gene-sequencing maker Illumina (ILMN.O), opens new tab, and current board member Scott Gottlieb will become chairman, the Wall Street Journal reported on Tuesday, citing people familiar with the matter. The changes are expected to be announced on Tuesday and will take effect on Friday, according to the report. Keep up with the latest medical breakthroughs and healthcare trends with the Reuters Health Rounds newsletter. Sign up here. Illumina and Keith Meister's hedge fund Corvex Management did not immediately respond to Reuters' requests for comment. Corvex Management owns about 1.7 million shares of Illumina, according to a regulatory filing. Shares of the company rose 2.2% in premarket trading, following the report.
